Spots Global Cancer Trial Database for seizures
Every month we try and update this database with for seizures cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | NCT00790400 | Tuberous Sclero... Lymphangioleiom... | Everolimus (RAD... Everolimus Plac... | 18 Years - | Novartis | |
Hypovitaminosis D in Neurocritical Patients | NCT02881957 | Craniocerebral ... Intracranial An... Brain Neoplasms Spinal Cord Inj... Seizures Meningitis Stroke Intracranial He... Critical Illnes... Vitamin d Defic... | Cholecalciferol Placebo | 18 Years - | University of Utah | |
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
Effect of Perampanel on Peritumoral Hyperexcitability in HGG | NCT04497142 | Glioma, Maligna... Surgery Seizures | Perampanel Standard of Car... | 18 Years - | Dana-Farber Cancer Institute | |
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | NCT04430842 | Astrocytoma Brain Cancer Brain Metastase... Bladder Cancer Breast Cancer Cervical Cancer Cholangiocarcin... Colorectal Canc... Esophagus Cance... Gastric Cancer Head and Neck C... Kidney Cancer Liver Cancer Lung Cancer Melanoma Ovarian Cancer Pancreatic Canc... Pleural Mesothe... Prostate Cancer Sarcoma Tongue Cancer Thymic Carcinom... Urinary Tract C... | QBS10072S | 18 Years - | Quadriga Biosciences, Inc. | |
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779 | Tuberous Sclero... | 1 Day - 6 Months | University of Alabama at Birmingham | ||
Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients | NCT01266291 | Complex Partial... | vigabatrin | 18 Years - | University of Pennsylvania | |
Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity | NCT05103735 | Craniotomy Seizures Dexmedetomidine Propofol Remifentanil Cerebral Tumor Neurophysiology | Propofol | 18 Years - | Azienda Sanitaria-Universitaria Integrata di Udine | |
Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
Trial of AEO in New Glioblastoma (GBM) | NCT04450160 | Glioblastoma Mu... | Anhydrous Enol-... Standard of Car... | 18 Years - | MetVital, Inc. | |
Neurology Inpatient Clinical Education Trial | NCT03826056 | Myasthenia Grav... Guillain-Barre ... Multiple Sclero... Seizures Parkinsonism Meningitis Encephalitis Headache Vestibular Diso... Spondylosis Normal Pressure... | Current standar... Personalized di... | 18 Years - 95 Years | Dartmouth-Hitchcock Medical Center | |
Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients | NCT01266291 | Complex Partial... | vigabatrin | 18 Years - | University of Pennsylvania | |
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
Levetiracetam Prophylaxis in Brain Tumor Resection Pilot | NCT05897658 | Seizures Brain Tumor | Levetiracetam Placebo | 18 Years - | Hamilton Health Sciences Corporation | |
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | NCT04076449 | Cavernous Malfo... Cavernous Angio... Cavernous Heman... Cavernous Heman... Seizures Seizures, Epile... Epilepsy | 18 Years - 70 Years | Beijing Tiantan Hospital | ||
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779 | Tuberous Sclero... | 1 Day - 6 Months | University of Alabama at Birmingham | ||
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | NCT04076449 | Cavernous Malfo... Cavernous Angio... Cavernous Heman... Cavernous Heman... Seizures Seizures, Epile... Epilepsy | 18 Years - 70 Years | Beijing Tiantan Hospital | ||
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
Glioblastoma Remote Monitoring and Care - Research Protocol | NCT06129760 | Glioblastoma Venous Thromboe... Seizures | Apple Watch | 18 Years - | Case Comprehensive Cancer Center | |
Levetiracetam Prophylaxis in Brain Tumor Resection Pilot | NCT05897658 | Seizures Brain Tumor | Levetiracetam Placebo | 18 Years - | Hamilton Health Sciences Corporation | |
Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity | NCT05103735 | Craniotomy Seizures Dexmedetomidine Propofol Remifentanil Cerebral Tumor Neurophysiology | Propofol | 18 Years - | Azienda Sanitaria-Universitaria Integrata di Udine | |
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | NCT04485104 | Seizure in Part... Seizure in Part... Seizure in Part... | GWP42003-P | 1 Month - 23 Months | Jazz Pharmaceuticals | |
Perampanel in Seizure Patients With Primary Glial Brain Tumors | NCT02363933 | Brain Tumor, Pr... | Perampanel | 18 Years - | Duke University | |
Seizures During Radiotherapy for High-grade Gliomas | NCT04552756 | High-grade Glio... | Seizure Diary | 18 Years - 85 Years | University Hospital Schleswig-Holstein | |
Basimglurant in Children, Adolescents, and Young Adults With TSC | NCT05059327 | Tuberous Sclero... | Basimglurant wi... Placebo with cr... | 5 Years - 30 Years | Noema Pharma AG |